ADXS
Advaxis, Inc.

275
Mkt Cap
$19.53M
Volume
11,254.00
52W High
$0.801
52W Low
$0.0011
Price
$0.458
ADXS Fundamentals
Prev Close
$0.40
Open
$0.4015
50D MA
$0.1148
Beta
-16.63
Avg. Volume
1,951.36
Loading...
Loading...
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. Its lead candidates are the oral gamma secretase inhibitor, AL102, for desmoid tumors, and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. The company was founded on June 5, 1987 and is headquartered in Monmouth Junction, NJ.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Ayala Pharmaceuticals Inc.?
What is the 52-week high for Ayala Pharmaceuticals Inc.?
What is the 52-week low for Ayala Pharmaceuticals Inc.?
What is Ayala Pharmaceuticals Inc. stock price today?
What was Ayala Pharmaceuticals Inc. stock price yesterday?
What is the 50-day moving average of Ayala Pharmaceuticals Inc.?

Latest ADXS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.